Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Comfort Systems USA Inc (FIX) vs Moderna, Inc. (MRNA) Price & Performance

Comfort Systems USA IncTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Comfort Systems USA Inc vs Moderna, Inc. — how do they compare? Comfort Systems USA Inc trades at $1,705.12 (market cap $58.94B), while Moderna, Inc. trades at $60.83 (market cap $23.88B). The key difference: Comfort Systems USA Inc is far larger — about 2.5× Moderna, Inc.'s market cap, and Comfort Systems USA Inc pays a 0.21% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

FIXMRNA
Market Cap
$58.94B$23.88B
Sector
TechnologyHealth
52-Week High
$2.07K$81.80
52-Week Low
$680.86$22.36
Enterprise Value
$57.42B$20.03B
Dividend Yield
0.21%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Comfort Systems USA Inc

FIX trades at $1,694.55, down 1.11% today, with a bearish technical signal from moving averages and RSI near overbought levels. The company reported strong Q2 2026 earnings, beating estimates with EPS of $12.53 versus $10.45 expected, driven by robust data center demand. Revenue grew to $11.2B in 2026, with net profit margin expanding to 12.77%. Analyst consensus is bullish with a $2,170 price target, though valuation multiples like P/E of 41.22 appear elevated.

Outlook remains positive given record backlog and AI-driven demand, but risks include high execution demands and premium valuation. The stock offers growth exposure to the construction and data center sectors, supported by institutional interest and consistent dividend payments, though investors should monitor capacity constraints and competitive pressures.

Moderna, Inc.

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Comfort Systems USA Inc

Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.

Read more on FIX

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA